Target intelligence / Profile preview

Protein chibby homolog 1 (CBY1)

Target
CBY1
Molecular classification
Other (antagonist of beta-catenin, negative regulator of Wnt signaling), Adapter protein (scaffolding function), Coiled-coil protein (structural classification)
01

Overview

Protein chibby homolog 1 (CBY1) is a small, evolutionarily conserved protein that acts as a key "antagonist of β-catenin" and a negative regulator of canonical Wnt/β-catenin signaling[1][3][4][5][6]. CBY1 exerts its function by binding directly to the C-terminal region of β-catenin, inhibiting its interaction with Tcf/Lef transcription factors, and thereby repressing β-catenin-mediated transcriptional activity[1][2][4][5]. CBY1 also forms a complex with β-catenin and 14-3-3 proteins, promoting β-catenin's nuclear export and further decreasing its transcriptional activation. In addition to its role in Wnt signaling, CBY1 is important for cellular differentiation—especially in adipogenesis and cardiomyocyte development—and is essential for ciliogenesis through its localization and function at centrioles and basal bodies[1][7]. Loss or downregulation of CBY1, through genetic mutation or promoter hypermethylation, leads to enhanced Wnt/β-catenin signaling and has been implicated in the pathogenesis of various cancers (including chronic myeloid leukemia, colorectal, gastric, and laryngeal carcinomas) as well as in ciliopathy syndromes such as Joubert syndrome[1][2][4]. Currently, CBY1 itself is not a direct therapeutic target for approved drugs, but its expression/status serves as a mechanistic marker for aberrant Wnt/β-catenin signaling in disease contexts[2][4][7].

Other names
Chibby1ChibbyARB1C22orf2CBYPGEA1HRIHFB2025PIGEA14PIGEA-14ARPP-binding proteinCytosolic leucine-rich proteinPKD2 interactorGolgi and endoplasmic reticulum-associated 1chibby CTNNB1-mediated transcription inhibitorchibby family member 1coiled-coil protein PIGEA-14polycystin-2 interactorGolgi- and endoplasmic reticulum-associated protein14 kDa
02

Mechanism of action

Negative regulation of β-catenin-mediated transcription by direct binding to β-catenin's C-terminal region, preventing interaction with Tcf/Lef transcription factors; Formation of a tripartite complex with β-catenin and 14-3-3 proteins, facilitating β-catenin nuclear export and reducing nuclear activity

03

Biological functions

Negative regulation of Wnt/β-catenin signalingPromotion of nuclear export of β-cateninRegulation of transcriptional activationModulation of cellular differentiation (including adipogenesis and cardiomyocyte differentiation)Ciliogenesis (centrioles and basal body function)
04

Disease associations

Cancer (colorectal carcinoma, chronic myeloid leukemia, laryngeal carcinoma, gastric carcinoma, pediatric ependymomas)Ciliopathies (Joubert syndrome)
05

Safety considerations

No specific safety concerns are documented for CBY1 modulation in humans, primarily due to lack of direct agonists/antagonists in clinical use. Any projection regarding safety would be speculative.
06

Biomarkers

Reduced expression or promoter hypermethylation of CBY1 can serve as a marker for enhanced β-catenin signaling and poor differentiation state in certain cancers (e.g., CML, colorectal carcinoma)CBY1 expression correlates with cellular differentiation in stem cell and cancer contexts

Beyond the preview

Go deeper on Protein chibby homolog 1 (CBY1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein chibby homolog 1 (CBY1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call